Roche Steps Back from RNAi, Cuts 6% of Staff; Closes Sites Nov. 24, 2010 By Catherine Shaffer No Comments
Inspiration Starts Hemophilia Phase II/III, Collects $50M Nov. 22, 2010 By Catherine Shaffer No Comments
Clavis Brings in $25.7M to Get AML Drug Through Phase III Nov. 19, 2010 By Catherine Shaffer No Comments
Roche Steps Back from RNA Interference, Cuts 6% of Staff Nov. 18, 2010 By Catherine Shaffer No Comments As part of a cost-cutting corporate restructuring, Roche AG plans to discontinue its preclinical research in the area of RNA interference (RNAi) at sites in Kulmbach, Germany; Madison, Wisc.; and Nutley, N.J. (BioWorld Today)Read More
NeoStem Fancies Progenitor, Raises $19M for Acquisition Nov. 17, 2010 By Catherine Shaffer No Comments
Targeted Genetics, Biocontrol Merge in Tech + Cash Marriage Nov. 15, 2010 By Catherine Shaffer No Comments
Ceregene Brings Home $11.5M for Parkinson's Gene Therapy Nov. 12, 2010 By Catherine Shaffer No Comments
Pfizer Seeks New Indications Using Biovista Bioinformatics Nov. 10, 2010 By Catherine Shaffer No Comments
NewCo News: CRO + Drug Discovery Helps DiscoveryBioMed Survive Nov. 5, 2010 By Catherine Shaffer No Comments
